Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
Details
Publication Year 2024-05-13,Volume 42,Issue #5,Page 850-868
Journal Title
Cancer Cell
Publication Type
Research article
Abstract
TP53-mutant blood cancers remain a clinical challenge. BH3-mimetic drugs inhibit BCL-2 pro-survival proteins, inducing cancer cell apoptosis. Despite acting downstream of p53, functional p53 is required for maximal cancer cell killing by BH3-mimetics through an unknown mechanism. Here, we report p53 is activated following BH3-mimetic induced mitochondrial outer membrane permeabilization, leading to BH3-only protein induction and thereby potentiating the pro-apoptotic signal. TP53-deficient lymphomas lack this feedforward loop, providing opportunities for survival and disease relapse after BH3-mimetic treatment. The therapeutic barrier imposed by defects in TP53 can be overcome by direct activation of the cGAS/STING pathway, which promotes apoptosis of blood cancer cells through p53-independent BH3-only protein upregulation. Combining clinically relevant STING agonists with BH3-mimetic drugs efficiently kills TRP53/TP53-mutant mouse B lymphoma, human NK/T lymphoma, and acute myeloid leukemia cells. This represents a promising therapy regime that can be fast-tracked to tackle TP53-mutant blood cancers in the clinic.
Publisher
Cell Press
Keywords
*Tumor Suppressor Protein p53/genetics; Humans; Animals; Mice; *Membrane Proteins/genetics; *Apoptosis/drug effects; Cell Line, Tumor; Mutation; Hematologic Neoplasms/drug therapy/genetics; Proto-Oncogene Proteins c-bcl-2/genetics; Peptide Fragments/pharmacology; Antineoplastic Agents/pharmacology/therapeutic use; Signal Transduction/drug effects; Proto-Oncogene Proteins/genetics; BH3-mimetic drugs; Sting; acute myeloid leukemia; apoptosis; blood cancer; lymphoma; p53
Department(s)
Clinical Haematology
Open Access at Publisher's Site
https://doi.org/10.1016/j.ccell.2024.04.004
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-07-04 04:37:43
Last Modified: 2024-07-04 04:49:35

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙